ASO Author Reflections: Timing of Oesophagectomy After Neoadjuvant Chemoradiotherapy for Locally Advanced Oesophageal Cancer
- PMID: 36322273
- DOI: 10.1245/s10434-022-12774-9
ASO Author Reflections: Timing of Oesophagectomy After Neoadjuvant Chemoradiotherapy for Locally Advanced Oesophageal Cancer
Comment on
-
Longer Time Interval from Neoadjuvant Chemoradiation to Surgery is Associated with Poor Survival for Patients Without Clinical Complete Response in Oesophageal Cancer.Ann Surg Oncol. 2023 Feb;30(2):886-896. doi: 10.1245/s10434-022-12758-9. Epub 2022 Nov 2. Ann Surg Oncol. 2023. PMID: 36322275 Free PMC article.
References
-
- Cliffton EE, Goodner JT, Bronstein E. Preoperative irradiation for cancer of the esophagus. Cancer. 1960;13:37–45. - DOI
-
- van de Schoot L, Romme EA, van der Sangen MJ, et al. A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer. Ann Surg Oncol. 2008;15(1):88–95. - DOI
-
- Shapiro J, van Hagen P, Lingsma HF, et al. Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer. Ann Surg. 2014;260(5):807–13. - DOI
-
- Nilsson K, Klevebro F, Rouvelas I, et al. Surgical morbidity and mortality from the multicenter randomized controlled NeoRes II Trial: standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2020;272(5):684–9. - DOI
-
- Xiao X, Cheng C, Cheng L, et al. Longer time interval from neoadjuvant chemoradiation to surgery is associated with poor survival for patients without clinical complete response in oesophageal cancer. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12758-9
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
